Global Postpartum Hemorrhage (PPH) Treatment Devices Market: Increasing Prevalence of Obesity and Hypertension among Women to Drive Demand, reports TMR

The global postpartum hemorrhage (PPH) treatment devices market is fragmented. Some of the strategies employed by players in the market are expansion of product portfolio and distribution network. Companies are competing with each other in terms of making the treatment devices affordable. However, the global postpartum hemorrhage (PPH) treatment market is expected to witness a high level threat of substitutes from pharmaceutical and surgical interventions, which are being preferred owing to a lack of awareness and reluctance to accept PPH treatment devices, especially in developing nations. New entrants, in order to sustain in the market have to make significant investments for establishment of their brands. New players have to face several barriers such as strong distribution requirement, compliance with stringent regulations, and cost competition, states a new report by Transparency Market Research (TMR). However, companies can enter the market by means of mergers and acquisitions. Overall, the threat of new entrants is expected to be moderate. 

According to the report, the global postpartum hemorrhage (PPH) treatment devices market is expected to rise from US$604.4 mn in 2014 to US$926.1 mn by 2023. On the basis of product, the uterine balloon tamponade market is expected to lead and be worth US$279.6 mn by 2023. This segment is also expected to witness a high CAGR of 5.3% from 2015 to 2023. On the basis of geography, Asia Pacific is expected to expand at a fast CAGR of 6.3% from 2015 to 2023. North America led in the past and is expected to lead in the coming years. North America is expected to be worth US$310.7 mn.

Awareness Campaigns and Government Initiatives to Create Awareness Driving Market

According to the systemic analysis report published in the Lancet in 2010, more than 350,000 women die from pregnancy-related complications and during childbirth across the world. A lack of skilled healthcare providers and inadequate communication and transportation systems are increasing the prevalence of postpartum hemorrhage, which is the loss of 500 ml blood or more. The growing awareness campaigns conducted by global non-profit organizations as well as educational and training programs by government will also drive the market for postpartum hemorrhage treatment devices.

The growing prevalence of obesity is increasing the risk of postpartum hemorrhage and this is also expected to fuel the demand for PPH treatment devices. In addition to this, many women are suffering from hypertension, which again increases the risk of PPH. Thus, the demand for postpartum hemorrhage treatment devices is expected to rise in the coming years as more and more women suffer from obstetric hemorrhage.

Low Acceptance of Unconventional Postpartum Hemorrhage Preventive Devices

Today, surgical interventions and drug therapies have become popular for the prevention of deaths occurring due to postpartum hemorrhage. To support this, there are several clinical studies that illustrate the safety and efficiency of these treatment methods. This is leading to a gradual decrease in the acceptance of postpartum hemorrhage treatment devices. Low awareness among people regarding PPH treatment devices is another key factor hampering the market. The awareness is particularly low in the developing nations of Asia Pacific, the Middle East and Africa.  However, players in the market are focusing on enhancing their distribution channels and awareness in these countries and this is expected to emerge as a growth opportunity.

This information is based on the findings of a report published by Transparency Market Research titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023.”

The report segments the global postpartum hemorrhage treatment devices market as:

Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products

  • Non-pneumatic Anti-shock Garment (NASG)
  • Uniject Prefilled Injection System
  • Uterine Balloon Tamponade
    • Foley Catheters
    • Condom Catheters
    • Others

Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America (LATAM)
  • Middle East & North Africa (MENA)
  • Rest of the World

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453